[1]
Matos , A. et al. 2025. sCD38 será a solução em doentes sob terapêutica com Daratumumab?. Proceedings of Research and Practice in Allied and Environmental Health. 2, 4 (out. 2025), 19. DOI:https://doi.org/10.26537/prpaeh.v2i4.6460.